These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 21164477

  • 1. Neuroscience: Angelman syndrome connections.
    Scheiffele P, Beg AA.
    Nature; 2010 Dec 16; 468(7326):907-8. PubMed ID: 21164477
    [No Abstract] [Full Text] [Related]

  • 2. Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model.
    Bruinsma CF, Schonewille M, Gao Z, Aronica EM, Judson MC, Philpot BD, Hoebeek FE, van Woerden GM, De Zeeuw CI, Elgersma Y.
    J Clin Invest; 2015 Nov 02; 125(11):4305-15. PubMed ID: 26485287
    [Abstract] [Full Text] [Related]

  • 3. Unraveling the mechanisms of Angelman Syndrome.
    Narasimhan K.
    Nat Neurosci; 2007 Mar 02; 10(3):275. PubMed ID: 17318219
    [No Abstract] [Full Text] [Related]

  • 4. [From pathogenesis to treatment of genetic intellectual disabilities: a lesson from Angelman syndrome research].
    Saitoh S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun 02; 33(3):127-30. PubMed ID: 25069246
    [Abstract] [Full Text] [Related]

  • 5. Neurodevelopmental disease: A molecular tightrope.
    Elgersma Y.
    Nature; 2015 Oct 01; 526(7571):50-1. PubMed ID: 26432241
    [No Abstract] [Full Text] [Related]

  • 6. Angelman syndrome, a genomic imprinting disorder of the brain.
    Chamberlain SJ, Lalande M.
    J Neurosci; 2010 Jul 28; 30(30):9958-63. PubMed ID: 20668179
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL.
    Hum Mol Genet; 2008 Jan 01; 17(1):111-8. PubMed ID: 17940072
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM, Reiter LT, Chamberlain SJ.
    Epigenomics; 2015 Oct 01; 7(7):1213-28. PubMed ID: 26585570
    [Abstract] [Full Text] [Related]

  • 12. Angelman syndrome - insights into a rare neurogenetic disorder.
    Buiting K, Williams C, Horsthemke B.
    Nat Rev Neurol; 2016 Oct 01; 12(10):584-93. PubMed ID: 27615419
    [Abstract] [Full Text] [Related]

  • 13. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
    Sun J, Liu Y, Zhu G, Cato C, Hao X, Qian L, Lin W, Adhikari R, Luo Y, Baudry M, Bi X.
    Sci Rep; 2020 Jun 17; 10(1):9824. PubMed ID: 32555345
    [Abstract] [Full Text] [Related]

  • 14. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES, Taylor-Blake B, Aita M, Simon JM, Philpot BD, Zylka MJ.
    J Neurosci; 2017 Oct 18; 37(42):10230-10239. PubMed ID: 28931574
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC, Hogart A, LaSalle JM.
    Hum Mol Genet; 2005 Feb 15; 14(4):483-92. PubMed ID: 15615769
    [Abstract] [Full Text] [Related]

  • 17. Germline mosaicism of a novel UBE3A mutation in Angelman syndrome.
    Hosoki K, Takano K, Sudo A, Tanaka S, Saitoh S.
    Am J Med Genet A; 2005 Oct 01; 138A(2):187-9. PubMed ID: 16100729
    [No Abstract] [Full Text] [Related]

  • 18. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
    Reiter LT, Seagroves TN, Bowers M, Bier E.
    Hum Mol Genet; 2006 Sep 15; 15(18):2825-35. PubMed ID: 16905559
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.
    Su H, Fan W, Coskun PE, Vesa J, Gold JA, Jiang YH, Potluri P, Procaccio V, Acab A, Weiss JH, Wallace DC, Kimonis VE.
    Neurosci Lett; 2011 Jan 07; 487(2):129-33. PubMed ID: 19563863
    [Abstract] [Full Text] [Related]

  • 20. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
    Sonzogni M, Hakonen J, Bernabé Kleijn M, Silva-Santos S, Judson MC, Philpot BD, van Woerden GM, Elgersma Y.
    Mol Autism; 2019 Jan 07; 10():23. PubMed ID: 31143434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.